BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21561394)

  • 1. Lacosamide as adjunctive therapy for partial-onset epileptic seizures: a review of the clinical and economic literature.
    Simoens S
    Curr Med Res Opin; 2011 Jul; 27(7):1329-38. PubMed ID: 21561394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial.
    Husain A; Chung S; Faught E; Isojarvi J; McShea C; Doty P
    Epilepsia; 2012 Mar; 53(3):521-8. PubMed ID: 22372628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Budget impact analysis of adjunctive therapy with lacosamide for partial-onset epileptic seizures in Belgium.
    Simoens S
    J Med Econ; 2011; 14(3):299-304. PubMed ID: 21488712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lacosamide: an adjunctive agent for partial-onset seizures and potential therapy for neuropathic pain.
    Harris JA; Murphy JA
    Ann Pharmacother; 2009 Nov; 43(11):1809-17. PubMed ID: 19843834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial.
    Chung S; Sperling MR; Biton V; Krauss G; Hebert D; Rudd GD; Doty P;
    Epilepsia; 2010 Jun; 51(6):958-67. PubMed ID: 20132285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial.
    Halász P; Kälviäinen R; Mazurkiewicz-Beldzińska M; Rosenow F; Doty P; Hebert D; Sullivan T;
    Epilepsia; 2009 Mar; 50(3):443-53. PubMed ID: 19183227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness of lacosamide in the adjunctive treatment of patients with refractory focal epilepsy in Belgium.
    Simoens S; De Naeyer L; Dedeken P
    CNS Drugs; 2012 Apr; 26(4):337-50. PubMed ID: 22452528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining the clinical utility of lacosamide: pooled analyses of three phase II/III clinical trials.
    Chung S; Ben-Menachem E; Sperling MR; Rosenfeld W; Fountain NB; Benbadis S; Hebert D; Isojärvi J; Doty P
    CNS Drugs; 2010 Dec; 24(12):1041-54. PubMed ID: 21090838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous lacosamide as short-term replacement for oral lacosamide in partial-onset seizures.
    Krauss G; Ben-Menachem E; Mameniskiene R; Vaiciene-Magistris N; Brock M; Whitesides JG; Johnson ME;
    Epilepsia; 2010 Jun; 51(6):951-7. PubMed ID: 20041945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and tolerability of adjunctive lacosamide intravenous loading dose in lacosamide-naive patients with partial-onset seizures.
    Fountain NB; Krauss G; Isojarvi J; Dilley D; Doty P; Rudd GD
    Epilepsia; 2013 Jan; 54(1):58-65. PubMed ID: 22708895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study.
    Runge U; Arnold S; Brandt C; Reinhardt F; Kühn F; Isensee K; Ramirez F; Dedeken P; Lauterbach T; Noack-Rink M; Mayer T
    Epilepsia; 2015 Dec; 56(12):1921-30. PubMed ID: 26526971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of lacosamide by focal seizure subtype.
    Sperling MR; Rosenow F; Faught E; Hebert D; Doty P; Isojärvi J
    Epilepsy Res; 2014 Oct; 108(8):1392-8. PubMed ID: 25082395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lacosamide for the treatment of epilepsy.
    Krauss GL; Edwards HB; Lin B
    Ann Med; 2012 Nov; 44(7):674-9. PubMed ID: 22380697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lacosamide as treatment of epileptic seizures - cost utility results for Sweden.
    Bolin K; Berggren F; Forsgren L
    Acta Neurol Scand; 2010 Jun; 121(6):406-12. PubMed ID: 20199516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacoeconomics of anti-epileptic drugs as adjunctive therapy for refractory epilepsy.
    Simoens S
    Expert Rev Pharmacoecon Outcomes Res; 2010 Jun; 10(3):309-15. PubMed ID: 20545595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy.
    Grosso S; Parisi P; Spalice A; Verrotti A; Balestri P
    Eur J Paediatr Neurol; 2014 Jan; 18(1):55-9. PubMed ID: 24129195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lacosamide: A Review in Focal Seizures in Patients with Epilepsy.
    Scott LJ
    Drugs; 2015 Dec; 75(18):2143-54. PubMed ID: 26607484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of levetiracetam: a review of three pivotal clinical trials.
    Privitera M
    Epilepsia; 2001; 42 Suppl 4():31-5. PubMed ID: 11564123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of adjunctive lacosamide among patients with partial-onset seizures in a long-term open-label extension trial of up to 8 years.
    Rosenfeld W; Fountain NB; Kaubrys G; Ben-Menachem E; McShea C; Isojarvi J; Doty P;
    Epilepsy Behav; 2014 Dec; 41():164-70. PubMed ID: 25461210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of lacosamide as an adjunctive therapy in children with refractory partial epilepsy.
    Pasha I; Kamate M; Didagi SK
    Pediatr Neurol; 2014 Oct; 51(4):509-14. PubMed ID: 25266613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.